# Study on the Effectiveness and Safety of Shuxinin Injection in the Treatment of Acute Ischemic Stroke

Study · id `cardio:ct-nct04950790` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04950790](<https://clinicaltrials.gov/study/NCT04950790>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04950790

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 480 participants.

## Technical summary

Registry record NCT04950790. Randomized; double masking; primary purpose treatment. Start 2018-04-01 (actual); primary completion 2021-12-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 480 participants (planned count; ClinicalTrials.gov record NCT04950790, source copy `cardio:ctgov-nct04950790-2021-07-07`, retrieved 2026-10-26)
- Started: 2018-04-01 (actual) (ClinicalTrials.gov record NCT04950790, source copy `cardio:ctgov-nct04950790-2021-07-07`, retrieved 2026-10-26)
- Primary completion: 2021-12-01 (anticipated) (ClinicalTrials.gov record NCT04950790, source copy `cardio:ctgov-nct04950790-2021-07-07`, retrieved 2026-10-26)
- Completion: 2021-12-01 (anticipated) (ClinicalTrials.gov record NCT04950790, source copy `cardio:ctgov-nct04950790-2021-07-07`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT04950790, source copy `cardio:ctgov-nct04950790-2021-07-07`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04950790-2021-07-07`, retrieved 2026-10-26)

## The registry's words

- Brief title: Study on the Effectiveness and Safety of Shuxinin Injection in the Treatment of Acute Ischemic Stroke
- Condition: Acute Ischemic Stroke
- Intervention (Drug): Shuxinin injection
- Intervention (Drug): Basic treatment
- Intervention (Drug): Placebo
- Lead sponsor: Peking University Third Hospital
- Lead sponsor class: OTHER
- Collaborator: Handan Central Hospital
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Peking University Third Hospital (`cardio:org-peking-university-third-hospital`)

## Provenance

Content hash: 9e0540fda73cac2f120453ae0b6c74973c6a87fb991ec0e7472785e5ff4726e1
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
